Circulating tumor cells (CTCs) five years after diagnosis are prognostic for late recurrence in operable stage II-III breast cancer Sparano, J. A., O'Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C., Sledge, G. W., Miller, K. D. AMER ASSOC CANCER RESEARCH. 2018

View details for Web of Science ID 000425489400039